# AbbVie Inc. (ABBV) — Q2-2023 Earnings Results

**Report date:** 2023-07-27 (before market open)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/ABBV/earnings/Q2-2023

## Post-Earnings Brief

### Headline

AbbVie Beats on EPS, Stock Up 4.9%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.91 | N/A | +4.49% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Unknown

No transcript is on record, and the analysis is based solely on numerical results.

### Guidance Changes

No guidance data is available for this quarter.

### What It Means

AbbVie reported a stronger-than-expected EPS, which led to a positive stock reaction, increasing by 4.9%. However, there was no revenue data provided, and no guidance updates were shared. Investors may view the EPS beat as a sign of underlying strength in the company's operations.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ABBV/earnings/Q2-2023_